Method and compositions for treating anxiety
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Sep 30, 2004
app pub date -
Nov 25, 2003
filing date -
Dec 4, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A method for treating anxiety in a patient by orally administering to said patient a daily dose of the active ingredient, 2-pyridinyl[7-(4-pyridinyl-)pyrazolo[1,5-a]-pyrimidin-3-yl]-methanone or its pharmaceutically acceptable salts especially Ocinaplonin, in two separate divided administrations, with the first portion being administered in a slow release form and the remaining portion being administered in instant release form so as to maintain the blood levels of this active ingredient at therapeutically relevant levels to keep the anti anxiety effect in the patient during the periods between administrations of this active ingredient as well as pharmaceutical compositions containing this active ingredient for administration in connection with the above method.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully